- In Vivo Originals
- Featured Topics
Leadership
Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.

-
Opinion
The Clinical Trial Accessibility Checklist: How Does Your Organization Measure Up?
By Jessica FedererThis year marks the 30th anniversary of the NIH revitalization act that required women and minorities to be included in clinical research in the US. Putting that into perspective, we have only really been collecting data at scale on women and minorities since the movie Jurassic Park was launched. If we want more people to participate in clinical trials, it is time to get real about reducing the burden of research on volunteers.

-
News
Execs On The Move: August 2023
By Barnaby PickeringAn interactive look at recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.

-
Interviews
Insitro’s Daphne Koller On The Marriage Of Biology And Machine Learning At The Company’s Heart
By Chloe KentIndustry veteran and serial entrepreneur Daphne Koller tells In Vivo about how her company, Insitro, is unleashing the potential of computational biology and machine learning to discover new drug compounds.

-
Interviews
Boehringer’s Innovation Strategy Does Not Avoid Areas With Heavy Competition
By Joseph HaasBI’s global head of innovation Michel Pairet tells In Vivo that while unmet medical need is the pharma’s R&D priority, its main focus is bringing breakthrough therapy potential to patients, and it is taking aim at competitive spaces like metabolic health and cancer.

-
Opinion
A Next-Gen Approach To Health Care Risk And Compliance
Across the health care industry, the increasing numbers of ethics violations, data breaches and reputational challenges reflect the growing magnitude and prevalence of compliance failures.

-
Interviews
Podcast: Creating A Digital Biotech Story
By Lucie Ellis-TaittIn this latest instalment of the In Vivo podcast Daniel Lofaso, CEO of Digital Elevator, talks about the common mistakes biotech companies make when trying to build their brand, how to connect with varied audiences and key trends the industry should keep track of in digital marketing.

-
Interviews
Exploring Alltrna’s Rare Disease Platform
By Janelle HartMichelle Werner, CEO of Alltrna, sat down with In Vivo to discuss rare disease as an increasingly important area of study, innovation in the space and how the emerging biotech hopes to impact the treatment landscape.

-
Interviews
AI Driving Innovation: Insights From Exscientia CEO Andrew Hopkins
By Lucie Ellis-Taitt and David WildAndrew Hopkins, founder and CEO of Exscientia, invented and championed an algorithmic approach to drug design and drug discovery. He talks to In Vivo about artificial intelligence in the biopharma industry today and what lies ahead.

-
Analysis
20 Years After First FDA Filing, Gepirone Finally Approaches Depression Market
By Lucie Ellis-TaittPrivate drug developer Fabre-Kramer is expecting approval for its antidepressant gepirone hydrochloride in September 2023. The drug has been rejected multiple times by the FDA as a treatment for major depressive disorder.

-
Analysis
Titans Of Pharma: Pfizer’s Bourla Tops Big Pharma CEO Compensation League
By Eleanor Malone and Kosh NaranInfographic: A snapshot of executive compensation at the world’s biggest pharmaceutical companies. Explore our interactive dashboard and visualizations comparing remuneration packages with other key company metrics.

-
Analysis
A Day Job And A Gay Job: How OUTbio Is Connecting LGBTQ Biotech Executives
By Chloe KentLGBTQ networking group OUTbio has gone from strength to strength since it was founded in 2015, from a small event attended by a handful of executives in Boston to a registered non-profit with affiliated groups across the US alongside international branches.

-
News
Execs On The Move: July 2023
By Barnaby PickeringAn interactive look at recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.

-
Analysis
Rethinking Commercialization Models In The Age Of Pricing And Access Complexity
By David WildIn an environment replete with pricing and patient access pressures, top biopharma companies are building commercialization models that emphasize inclusive and diverse decision-making and that integrate digital tools with a human salesforce.

-
Interviews
J&J Leans Into The Patient Opportunity In Vision
By Ashley YeoJacqueline Henderson was appointed president, Johnson & Johnson Vision, EMEA, in April, as part of a restructuring of senior regional roles. Now overseeing this most culturally diverse of territories for both Vision Care and Surgical Vision, she explains the rationale for the internal realignment and where Johnson & Johnson Vision goes next.

-
Interviews
Marinus On Track To Be Leader In Rare Epilepsy Market, Says CEO
By Lucie Ellis-TaittCEO Scott Braunstein, who took leadership of Marinus in 2019 following clinical trial setbacks, believes the company is on a route to success with its ganaxolone program, targeting chronic use and hospital markets.

-
Interviews
AI Medical Technology: The Trials, Tribulations And Motivations Behind A Start-Up
By Barnaby PickeringChristoffer Ekström, one of In Vivo's 2023 Rising Leaders, spoke about the challenges a start-up founder faces, the importance of never giving up and how one should always learn from the past.
Email Article
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.